Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database

Abstract

Non-ARV use by PWHIV is high and increases with age. Treatment decisions for ageing PWHIV should consider guideline recommendations for comorbidities.